ICD Therapy Confers No Survival Advantage in a Global LVAD Population: Insights from the Trans-Atlantic Registry on VAD and Transplant (TRAViATA)

O Braun; M Brambatti; P Shah; M Cipriani; Jesse Veenis; Q Bui; K Hong; CV de Heyning; E Perna; P Timmermans; M Cikes; G Gjesdal; C Partida; L Potena; M Masetti; A Loforte; N Jakus; J Nilsson; D De Bock; J Minto; Jasper Brugts; C Sterken; K Van den Bossche; F Rega; R Sing; C Russo; V Pretorius; L Klein; M Frigerio; E Adler; E Ammirati

doi:10.1016/j.healun.2020.01.783

ICD Therapy Confers No Survival Advantage in a Global LVAD Population: Insights from the Trans-Atlantic Registry on VAD and Transplant (TRAViATA)

O Braun
, M Brambatti
, P Shah
, M Cipriani
, Jesse Veenis
, Q Bui
, K Hong
, CV de Heyning
, E Perna
, P Timmermans
, M Cikes
, G Gjesdal
, C Partida
, L Potena
, M Masetti
, A Loforte
, N Jakus
, J Nilsson
, D De Bock
, J Minto

Jasper Brugts, C Sterken, K Van den Bossche, F Rega, R Sing, C Russo, V Pretorius, L Klein, M Frigerio, E Adler, E Ammirati

Cardiology

Research output: Contribution to journal › Article › Academic

Original language	English
Pages (from-to)	S191
Journal	The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Volume	39
Issue number	4
DOIs	https://doi.org/10.1016/j.healun.2020.01.783
Publication status	Published - 2020

Research programs

EMC COEUR-09

Access to Document

10.1016/j.healun.2020.01.783

Cite this

Braun, O., Brambatti, M., Shah, P., Cipriani, M., Veenis, J., Bui, Q., Hong, K., de Heyning, CV., Perna, E., Timmermans, P., Cikes, M., Gjesdal, G., Partida, C., Potena, L., Masetti, M., Loforte, A., Jakus, N., Nilsson, J., De Bock, D., ... Ammirati, E. (2020). ICD Therapy Confers No Survival Advantage in a Global LVAD Population: Insights from the Trans-Atlantic Registry on VAD and Transplant (TRAViATA). The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 39(4), S191. https://doi.org/10.1016/j.healun.2020.01.783

@article{fdb24cb526bc4875bd5d3655baf1bb5d,

title = "ICD Therapy Confers No Survival Advantage in a Global LVAD Population: Insights from the Trans-Atlantic Registry on VAD and Transplant (TRAViATA)",

author = "O Braun and M Brambatti and P Shah and M Cipriani and Jesse Veenis and Q Bui and K Hong and \{de Heyning\}, CV and E Perna and P Timmermans and M Cikes and G Gjesdal and C Partida and L Potena and M Masetti and A Loforte and N Jakus and J Nilsson and \{De Bock\}, D and J Minto and Jasper Brugts and C Sterken and \{Van den Bossche\}, K and F Rega and R Sing and C Russo and V Pretorius and L Klein and M Frigerio and E Adler and E Ammirati",

year = "2020",

doi = "10.1016/j.healun.2020.01.783",

language = "English",

volume = "39",

pages = "S191",

journal = "The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation",

issn = "1557-3117",

publisher = "Elsevier Inc.",

number = "4",

}

Braun, O, Brambatti, M, Shah, P, Cipriani, M, Veenis, J, Bui, Q, Hong, K, de Heyning, CV, Perna, E, Timmermans, P, Cikes, M, Gjesdal, G, Partida, C, Potena, L, Masetti, M, Loforte, A, Jakus, N, Nilsson, J, De Bock, D, Minto, J, Brugts, J, Sterken, C, Van den Bossche, K, Rega, F, Sing, R, Russo, C, Pretorius, V, Klein, L, Frigerio, M, Adler, E & Ammirati, E 2020, 'ICD Therapy Confers No Survival Advantage in a Global LVAD Population: Insights from the Trans-Atlantic Registry on VAD and Transplant (TRAViATA)', The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, vol. 39, no. 4, pp. S191. https://doi.org/10.1016/j.healun.2020.01.783

ICD Therapy Confers No Survival Advantage in a Global LVAD Population: Insights from the Trans-Atlantic Registry on VAD and Transplant (TRAViATA). / Braun, O; Brambatti, M; Shah, P et al.
In: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, Vol. 39, No. 4, 2020, p. S191.

Research output: Contribution to journal › Article › Academic

TY - JOUR

T1 - ICD Therapy Confers No Survival Advantage in a Global LVAD Population: Insights from the Trans-Atlantic Registry on VAD and Transplant (TRAViATA)

AU - Braun, O

AU - Brambatti, M

AU - Shah, P

AU - Cipriani, M

AU - Veenis, Jesse

AU - Bui, Q

AU - Hong, K

AU - de Heyning, CV

AU - Perna, E

AU - Timmermans, P

AU - Cikes, M

AU - Gjesdal, G

AU - Partida, C

AU - Potena, L

AU - Masetti, M

AU - Loforte, A

AU - Jakus, N

AU - Nilsson, J

AU - De Bock, D

AU - Minto, J

AU - Brugts, Jasper

AU - Sterken, C

AU - Van den Bossche, K

AU - Rega, F

AU - Sing, R

AU - Russo, C

AU - Pretorius, V

AU - Klein, L

AU - Frigerio, M

AU - Adler, E

AU - Ammirati, E

PY - 2020

Y1 - 2020

U2 - 10.1016/j.healun.2020.01.783

DO - 10.1016/j.healun.2020.01.783

M3 - Article

SN - 1557-3117

VL - 39

SP - S191

JO - The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

JF - The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

IS - 4

ER -

Braun O, Brambatti M, Shah P, Cipriani M, Veenis J, Bui Q et al. ICD Therapy Confers No Survival Advantage in a Global LVAD Population: Insights from the Trans-Atlantic Registry on VAD and Transplant (TRAViATA). The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2020;39(4):S191. doi: 10.1016/j.healun.2020.01.783